Jeffrey Kronson, MD
Vascular Surgery · Arcadia, CANPI 1942219225
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (47.8%), other and education — rather than concentrated in one kind of arrangement. 13 manufacturers reported payments, led by Boston Scientific at 49.6% of the total. Reporting peaked in 2022 at $38,781 and has fallen 86.8% since, to $5,126 in 2025. Among vascular surgery clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 88 payments — averaging $781.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$34K
- Angiodynamics, Inc.$34K
- Medtronic$175
- Biocompatibles, Inc.$124
- Bard Peripheral Vascular, Inc.$110
- Mindray DS USA, Inc.$92
- plus $273 from 7 others
What the payments were for
- Speaking & faculty fees$32,90048%
- Food & beverage$2,3113%
- Education$14,40021%
- Other$19,20028%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 49 | $34,110 |
| Angiodynamics, Inc. | 16 | $33,927 |
| Medtronic(2 entities) | 2 | $175 |
| Biocompatibles, Inc. | 2 | $124 |
| Bard Peripheral Vascular, Inc. | 4 | $110 |
| Mindray DS USA, Inc. | 3 | $92 |
| Medline Industries LP | 3 | $74 |
| Johnson & Johnson | 2 | $58 |
| Tactile Systems Technology Inc | 2 | $44 |
| Organogenesis Inc. | 2 | $40 |
| Philips North America LLC | 1 | $28 |
| Cardiovascular Systems Inc. | 1 | $18 |
| Venclose Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Varithena Administration Pack$33,345
- VenaCure 1470 Pro$24,000
- EVLT$9,600
- Valiant Captivia$127
- VARITHENA$107
How this compares
$68,811 in reported general payments places this provider in the 90th percentile of 519 vascular surgery providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 14 | $7,875 |
| ClopidogrelClopidogrel Bisulfate | 59 | $765 |
| Tramadol Hcl | 42 | $80 |
| Diazepam | 37 | $33 |
Paid to pharmacies, not to this prescriber.
Other vascular surgery in Arcadia
- Son DuongFountain Valley$503K
- Venita ChandraPalo Alto$488K
- Sukgu HanLos Angeles$477K
- Leigh Ann ObanionFresno$469K
- Trevor DerderianRancho Mirage$359K
- Karthikeshwar KasirajanPalo Alto$349K
- Johnathon RolloLos Angeles$337K
- Melissa LojaFairfield$272K
- Jason LeePalo Alto$228K
- John LaneSan Diego$212K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.